Huafeng Zhang

Dr. Huafeng Zhang

First affiliated hospital of Zhengzhou University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2021 in Biological Trace Element Research
Verified
Journal Article
Closed access
YFYonggang Fan
Yonggang Fan
SNShuangfei Ni
Shuangfei Ni
HZHuafeng Zhang
Huafeng Zhang

1 January 2021 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
SNShuangfei Ni
Shuangfei Ni
BYBo Yang
Bo Yang
LXLei Xia
Lei Xia
HZHuafeng Zhang
Huafeng Zhang
Acute spinal cord injury (ASCI) is a severe traumatic disease of the central nervous system, the underlying mechanism of which is unclear. This study was intended to study the role of EZH2 and miR‐146a‐5p/HIF‐1α in inflammation and glycolysis after ASCI, providing reference and basis for the clinical treatment and prognosis of ASCI injury. We used lipopolysaccharide (LPS) to induce inflammation of microglia, and we constructed the ASCI animal model. qRT‐PCR detected the relative expression levels of EZH2, HIF‐1α, miR‐146a‐5p, IL‐6, TNF‐α, IL‐17, PKM2, GLUT1, and HK2 in cells and tissues. Western blot was performed to detect the expression levels of EZH2, HIF‐1α, H3K27me3, IL‐6, TNF‐α, IL‐17, PKM2, GLUT1, and HK2. ChIP verified the enrichment of H3K27me3 in the miR‐146a‐5p promoter region. Bioinformatics predicted the binding sites of HIF‐1α and miR‐146a‐5p, and dual‐luciferase reporter assay verified the binding of HIF‐1α and miR‐146a‐5p. ELISA detects the levels of inflammatory factors IL‐6, TNF‐α, and IL‐17 in the cerebrospinal fluid of rats. The GC‐TOFMS was used to detect the changes of glycolytic metabolites in the cerebrospinal fluid of rats. EZH2 could mediate inflammation and glycolysis of microglia. EZH2 regulates inflammation and glycolysis through HIF‐1α. EZH2 indirectly regulated the HIF‐1α expression by mediating miR‐146a‐5p. EZH2 mediates miR‐146a‐5p/HIF‐1α to alleviate inflammation and glycolysis in ASCI rats. In the present study, our results demonstrated that EZH2 could mediate miR‐146a‐5p/HIF‐1α to alleviate the inflammation and glycolysis after ASCI. Therefore, EZH2/miR‐146a‐5p/HIF‐1α might be a novel potential target for treating ASCI.


1 May 2021 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
DLDongzhe Li
Dongzhe Li
TYTengyue Yang
Tengyue Yang
CSChenglong Shao
Chenglong Shao
ZCZhengming Cao
Zhengming Cao
HZHuafeng Zhang
Huafeng Zhang


10 June 2024 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Closed access
PDF file
SNShuangfei Ni
Shuangfei Ni
XHXiusheng Huang
Xiusheng Huang
XLXuesen Li
Xuesen Li
CSChenhao Shi
Chenhao Shi
MFMingzhe Fan
Mingzhe Fan
HZHuafeng Zhang
Huafeng Zhang
Background: Nucleus pulposus cell (NPC) senescence in intervertebral disc (IVD) tissue is the major pathological cause of intervertebral disc degeneration (IDD). N6-methyladenosine (m6A) methylation and gut microbiota play important roles in the progression of IDD. This study investigated whether methyltransferase-like 3 (METTL3) regulates TLR2 m6A modification and gut microbiota to influence NPC senescence. Methods: An IDD rat model was established by lumbar IVD puncture and NPCs were challenged with IL-1β to mimic IVD injury. IDD rats and IL-1β-exposed NPCs were treated with METTL3-interfering lentivirus and the TLR2 agonist Pam3CSK4. Compositional changes in the rat gut microbiota were analyzed and fecal microbiota transplantation procedures were used. NPC senescence, cell cycle, and the expression of senescence-associated secretory phenotype (SASP) factors were assessed. The m6A enrichment of TLR2 and the binding of IGF2BP1 to TLR2 mRNA were examined. Results: METTL3 and TLR2 were highly expressed in IDD rats. METTL3 silencing attenuated senescent phenotypes and reduced secretion of SASP factors. Pam3CSK4 reversed the beneficial effects of METTL3 silencing on NPC senescence and IVD injury. METTL3 stabilized TLR2 mRNA in an IGF2BP1-dependent manner. METTL3 silencing restored specific gut microbiota levels in IDD rats, which was further reversed by administration of Pam3CSK4. Fecal microbiota from METTL3 silenced IDD rats altered the pathological phenotypes of IDD rats. Conclusions: These results demonstrate the beneficial effects of METTL3 silencing on NPC senescence and amelioration of IVD injury, involving modulation of TLR2 m6A modification and gut microbiota. These findings support METTL3 silencing as a potential therapeutic target for IDD.